Language
English
Publication Date
10-25-2023
Journal
Nano Letters
DOI
10.1021/acs.nanolett.3c02137
PMID
37787444
PMCID
PMC11375454
PubMedCentral® Posted Date
9-5-2024
PubMedCentral® Full Text Version
Author MSS
Abstract
Inadequate drug loading and control of payload leakage limit the duration of the effect of liposomal drug carriers and may cause toxicity. Here, we report a liposome system as a depot for sustained drug delivery whose design is inspired by the low permeability of Archaeal membranes to protons and solutes. Incorporating methyl-branched phospholipids into lipid bilayers decreased payload diffusion across liposomal membranes, thereby enhancing the drug load capacity by 10-16% and reducing the release of small molecules in the first 24 h by 40-48%. The in vivo impact of this approach was demonstrated by injection at the sciatic nerve. Methyl-branched liposomes encapsulating the anesthetic tetrodotoxin (TTX) achieved markedly prolonged local anesthesia lasting up to 70 h, in comparison to the 16 h achieved with liposomes containing conventional lipids. The present work demonstrates the usefulness of methyl-branched liposomes to enhance liposomal depot systems for sustained drug delivery.
Keywords
Liposomes, Drug Delivery Systems, Drug Carriers, Phospholipids, Lipid Bilayers
Published Open-Access
yes
Recommended Citation
Li, Yang; Shao, Rachelle; Ostertag-Hill, Claire A; et al., "Methyl-Branched Liposomes as a Depot for Sustained Drug Delivery" (2023). Duncan NRI Faculty and Staff Publications. 247.
https://digitalcommons.library.tmc.edu/duncar_nri_pub/247
Included in
Genetic Phenomena Commons, Medical Genetics Commons, Neurology Commons, Neurosciences Commons